Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nano-LCMS Differentiates Liver Diseases

By LabMedica International staff writers
Posted on 24 Sep 2018
Non-alcoholic steatohepatitis (NASH) is among the leading causes of liver disease worldwide. More...
It is increasingly recognized that the phenotype of NASH may involve a number of different pathways, of which each could become important therapeutic targets.

In addition to the clinical factors associated with adverse outcomes in NASH, a number of studies have assessed histologic features associated with mortality. In this context, the presence of histologic inflammation and ballooning degeneration of hepatocytes can be associated with advanced hepatic fibrosis in patients with NASH, but not mortality.

Doctors at the Inova Fairfax Hospital (Falls Church, VA, USA) and their colleagues studied a cohort that included 67 obese patients who underwent a liver biopsy for clinical indications. Histological diagnosis was made by the study hepatopathologist and patients were classified into groups: 42 NASH Non-alcoholic fatty liver disease (NAFLD) and 24 non-NASH NAFLD (simple steatosis) or five patients with fibrosis stage ≥ 2) and three fibrosis stage ˂ 2. Blood samples, liver tissue, and demographic and clinical data were collected at the time of liver biopsy.

All liver biopsies were stained with hematoxylin and eosin and Sirius red for steatosis and collagen quantification. Collagen quantification was performed following the acquisition of digitalized images of Sirius stained slides with an Aperio Scanscope XT slide scanner. Serum proteomics were analyzed using liquid chromatography (LC) coupled tandem MS (LC–MS/MS) with an LTQ-Orbitrap mass spectrometer.

The scientists reported that phosphorylated signaling pathways in the liver revealed that apoptosis signal-regulating kinase 1, mitogen-activated protein kinase (ASK1-MAPK pathway involving ASK1 S38 and p38 MAPK) activated by the inflammatory cytokine interleukin (IL-10) were independently associated with higher percentage collagen. LC-MS data revealed that serum alpha-2 macroglobulin (α2M) and coagulation factor V were independently associated with higher percentage hepatic collagen.

The authors concluded that simultaneous profiling of serum proteome and hepatic phosphoproteome revealed that the activation of ASK1 S38, p38 MAPK in the liver, and serum α2M and coagulation factor V are independently associated with hepatic collagen deposition in patients with NASH. These data suggest the role of these pathways in the pathogenesis of NASH-related fibrosis as a potential therapeutic target. The study was published on September 12, 2018, in the journal BMC Medicine.

Related Links:
Inova Fairfax Hospital


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
POC Immunoassay Analyzer
Procise DX
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.